Comparative effectiveness of beta-interferons and glatiramer acetate for relapsing-remitting multiple sclerosis : systematic review and network meta-analysis of trials including recommended dosages
| dc.contributor.author | Melendez-Torres, G. J. | |
| dc.contributor.author | Armoiry, Xavier | |
| dc.contributor.author | Court, Rachel | |
| dc.contributor.author | Patterson, Jacoby | |
| dc.contributor.author | Kan, Alan | |
| dc.contributor.author | Auguste, Peter | |
| dc.contributor.author | Madan, Jason | |
| dc.contributor.author | Counsell, Carl | |
| dc.contributor.author | Ciccarelli, Olga | |
| dc.contributor.author | Clarke, Aileen | |
| dc.contributor.institution | University of Aberdeen.Grampian Data Safe Haven (DaSH) | en |
| dc.contributor.institution | University of Aberdeen.Chronic Disease Research Group | en |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
| dc.date.accessioned | 2018-10-17T15:20:24Z | |
| dc.date.available | 2018-10-17T15:20:24Z | |
| dc.date.issued | 2018-10-03 | |
| dc.description | This work is part of a larger report commissioned by the NIHR HTA Programme as project number ID809. Aileen Clarke and G.J. Melendez-Torres are partly supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care West Midlands at the University Hospitals Birmingham NHS Foundation Trust. The views expressed are those of the authors and not necessarily those of the NHS, NIHR, NICE or the Department of Health and Social Care. | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 863759 | |
| dc.identifier | 140000548 | |
| dc.identifier | 1e0986b2-175c-49bd-9576-cb55fb84357c | |
| dc.identifier | 85054381653 | |
| dc.identifier.citation | Melendez-Torres, G J, Armoiry, X, Court, R, Patterson, J, Kan, A, Auguste, P, Madan, J, Counsell, C, Ciccarelli, O & Clarke, A 2018, 'Comparative effectiveness of beta-interferons and glatiramer acetate for relapsing-remitting multiple sclerosis : systematic review and network meta-analysis of trials including recommended dosages', BMC Neurology, vol. 18, 162. https://doi.org/10.1186/s12883-018-1162-9 | en |
| dc.identifier.doi | 10.1186/s12883-018-1162-9 | |
| dc.identifier.issn | 1471-2377 | |
| dc.identifier.other | RIS: urn:E9C520A36BFECC63274148314181CD8F | |
| dc.identifier.other | RIS: Melendez-Torres2018 | |
| dc.identifier.other | ORCID: /0000-0001-6622-7839/work/164505693 | |
| dc.identifier.uri | http://hdl.handle.net/2164/11266 | |
| dc.identifier.vol | 18 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | BMC Neurology | en |
| dc.subject | multiple sclerosis | en |
| dc.subject | clinically isolated syndrome | en |
| dc.subject | beta-interferon | en |
| dc.subject | glatiramer acetate | en |
| dc.subject | systematic review | en |
| dc.subject | economic evaluation | en |
| dc.subject | R Medicine | en |
| dc.subject | National Institute for Health Research (NIHR) | en |
| dc.subject.lcc | R | en |
| dc.title | Comparative effectiveness of beta-interferons and glatiramer acetate for relapsing-remitting multiple sclerosis : systematic review and network meta-analysis of trials including recommended dosages | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Comparative_effectiveness_of_beta_interferons_and_glatiramer_acetate_for_relapsing_remitting_multiple_sclerosis.pdf
- Size:
- 843.51 KB
- Format:
- Adobe Portable Document Format
License bundle
1 - 1 of 1
